Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology and ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances; generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.
Sun Pharmaceutical Industries Dividend Announcement
• Sun Pharmaceutical Industries announced a semi annually dividend of ₹5.00 per ordinary share which will be made payable on 2024-08-16. Ex dividend date: 2024-07-12
• Sun Pharmaceutical Industries annual dividend for 2024 was ₹13.50
• Sun Pharmaceutical Industries annual dividend for 2023 was ₹11.50
• Sun Pharmaceutical Industries's trailing twelve-month (TTM) dividend yield is 0.75%
• Sun Pharmaceutical Industries's dividend growth over the last five years (2018-2023) was 41.88% year
• Sun Pharmaceutical Industries's dividend growth over the last ten years (2013-2023) was 16.49% year
Sun Pharmaceutical Industries Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-07-12 | ₹5.00 | semi annually | 2024-08-16 |
2024-02-09 | ₹8.50 | semi annually | |
2023-07-28 | ₹4.00 | semi annually | 2023-09-08 |
2023-02-08 | ₹7.50 | semi annually | 2023-03-02 |
2022-08-19 | ₹3.00 | semi annually | 2022-09-20 |
2022-02-09 | ₹7.00 | semi annually | 2022-02-22 |
2021-08-23 | ₹2.00 | semi annually | 2021-09-17 |
2021-02-09 | ₹5.50 | semi annually | 2021-02-19 |
2020-08-19 | ₹1.00 | semi annually | 2020-09-01 |
2020-02-17 | ₹3.00 | semi annually | 2020-02-24 |
2019-08-20 | ₹2.75 | semi annually | 2019-08-30 |
2018-09-17 | ₹2.00 | semi annually | 2018-10-01 |
2017-09-18 | ₹3.50 | semi annually | 2017-10-26 |
2016-09-08 | ₹1.00 | semi annually | 2016-10-17 |
2015-10-21 | ₹3.00 | semi annually | 2015-11-30 |
2014-09-11 | ₹1.50 | semi annually | 2014-09-30 |
2013-09-19 | ₹2.50 | semi annually | 2013-10-30 |
Sun Pharmaceutical Industries Dividend per year
Sun Pharmaceutical Industries Dividend growth
Sun Pharmaceutical Industries Dividend Yield
Sun Pharmaceutical Industries current trailing twelve-month (TTM) dividend yield is 0.75%. Interested in purchasing Sun Pharmaceutical Industries stock? Use our calculator to estimate your expected dividend yield:
Sun Pharmaceutical Industries Financial Ratios
Sun Pharmaceutical Industries Dividend FAQ
Other factors to consider when evaluating Sun Pharmaceutical Industries as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Sun Pharmaceutical Industries stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Sun Pharmaceutical Industries's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Sun Pharmaceutical Industries publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Sun Pharmaceutical Industries distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Sun Pharmaceutical Industries are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Sun Pharmaceutical Industries sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Sun Pharmaceutical Industries distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Sun Pharmaceutical Industries declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Sun Pharmaceutical Industries's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Sun Pharmaceutical Industries's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.